Stockscreener 앱 받기
27.90
1.41%
-0.40
시간 외 거래:
27.90
전일 마감가:
$28.30
열려 있는:
$28.11
하루 거래량:
962.80K
Relative Volume:
1.19
시가총액:
$1.16B
수익:
$656.32M
순이익/손실:
$-164.17M
주가수익비율:
-9.3643
EPS:
-2.9794
순현금흐름:
$12.90M
1주 성능:
+9.76%
1개월 성능:
+4.46%
6개월 성능:
-37.32%
1년 성능:
-45.66%
1일 변동 폭
$27.57
$28.30
1주일 범위
$23.91
$29.08
52주 변동 폭
$23.91
$63.58
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
AZTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
27.90 | 1.16B | 656.32M | -164.17M | 12.90M | -2.9794 |
|
ISRG
Intuitive Surgical Inc
|
563.95 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
93.25 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
247.65 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.76 | 16.11B | 3.93B | 415.40M | 384.70M | 2.06 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta (AZTA) Partners with Form Bio to Advance AAV Gene Therapy - GuruFocus
Azenta, Form Bio Launch Partnership for AAV Gene Therapy - marketscreener.com
Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development - marketscreener.com
Azenta Life Sciences and Form Bio Announce Strategic Partnership - GuruFocus
Azenta, Form Bio announce strategic partnership - TipRanks
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PR Newswire
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Voya Investment Management LLC - Defense World
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha
Needham & Company LLC Lowers Azenta (NASDAQ:AZTA) Price Target to $40.00 - Defense World
Balance Sheet Insights: Azenta Inc (AZTA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 - MSN
Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey
First Trust Advisors LP Buys New Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo
Azenta (NASDAQ:AZTA) Hits New 1-Year Low Following Weak Earnings - Defense World
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic Challenges - GuruFocus
Azenta, Inc. Reports Solid Q2 2025 Revenue Growth - TipRanks
Azenta, Inc. Reports Strong Q2 2025 Earnings - TipRanks
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stoc - GuruFocus
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion By Investing.com - Investing.com South Africa
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus
Transcript : Azenta, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com
Needham Adjusts Price Target on Azenta to $40 From $59, Keeps Buy Rating - marketscreener.com
Earnings call transcript: Azenta’s Q2 2025 results miss EPS forecast, stock rises - Investing.com Australia
Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion - Investing.com India
Azenta Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com
Azenta Surpasses Revenue Expectations in Q1 CY2025News and Statistics - IndexBox
Azenta (NASDAQ:AZTA) Beats Q1 Sales Targets - FinancialContent
Azenta (AZTA) Reports Q2 Earnings with Revenue Decline - GuruFocus
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 | AZTA Stock News - GuruFocus
Azenta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
Azenta expands PCR plate range - European Pharmaceutical Manufacturer
S&P Dow Jones Indices Announces Changes to MidCap 400 and SmallCap 600 - SDx Central
Top investors say Azenta Inc (AZTA) ticks everything they need - Sete News
Examining Azenta Inc (AZTA) stock is warranted - uspostnews.com
Azenta Inc [AZTA] Insider Hughes Violetta sells 317 Shares - knoxdaily.com
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast - Kilgore News Herald
Raymond James Financial Inc. Purchases Shares of 46,612 Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA)’s Market Momentum: Closing Strong at 27.02, Up 1.08 - DWinneX
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast | AZTA Stock News - GuruFocus
AZTA Stock Sees Decline of Approximately -0.42% in Last Five Days - knoxdaily.com
Invesco Ltd. Acquires 61,678 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Russell Investments Group Ltd. Boosts Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Bank of Montreal Can Has $455,000 Position in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta, Inc. (NASDAQ:AZTA) Holdings Decreased by Alliancebernstein L.P. - Defense World
Franklin Resources Inc. Acquires New Shares in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta, Inc. - The Bradford Era
Azenta: Life Science Business Failing To Come To Life (NASDAQ:AZTA) - Seeking Alpha
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Envestnet Asset Management Inc. - Defense World
Wells Fargo & Company MN Reduces Stock Position in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.71%
0.75%
자본화:
|
볼륨(24시간):